Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Poitiers University Hospital
Washington University School of Medicine
Institut Cancerologie de l'Ouest
Institut de Cancérologie de Lorraine
Wake Forest University Health Sciences
Centre Oscar Lambret
Institut du Cancer de Montpellier - Val d'Aurelle
Institut du Cancer de Montpellier - Val d'Aurelle
Abramson Cancer Center at Penn Medicine
Memorial Sloan Kettering Cancer Center
Poitiers University Hospital
Poitiers University Hospital
The Netherlands Cancer Institute
Institut Curie
Assistance Publique - Hôpitaux de Paris
Austrian Breast & Colorectal Cancer Study Group
University of Wisconsin, Madison
Institut Curie
UNC Lineberger Comprehensive Cancer Center
Centre Georges Francois Leclerc
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
Institut du Cancer de Montpellier - Val d'Aurelle
Institut du Cancer de Montpellier - Val d'Aurelle
University Hospital Augsburg
Memorial Sloan Kettering Cancer Center
Centre Francois Baclesse
Centre Hospitalier Henri Duffaut - Avignon
UNICANCER
Washington University School of Medicine
Centre Hospitalier Universitaire de la Réunion
Case Comprehensive Cancer Center
Universitaire Ziekenhuizen KU Leuven
Assistance Publique Hopitaux De Marseille
Centre Georges Francois Leclerc
Memorial Sloan Kettering Cancer Center
Ospedale Policlinico San Martino
Centre Francois Baclesse, Luxembourg
University of Arkansas
Washington University School of Medicine
Hospices Civils de Lyon
Kahramanmaras Sutcu Imam University
Centre Leon Berard
University of Wisconsin, Madison
Washington University School of Medicine
Case Comprehensive Cancer Center
Centre Leon Berard
Vanderbilt-Ingram Cancer Center